# CDC 2023 Hepatitis B Screening and Testing Recommendations

OpenHBV source page: https://openhbv.bangbo.dev/sources/cdc-2023-hepatitis-b-screening-and-testing-recommendations?locale=en
Canonical Markdown: https://openhbv.bangbo.dev/sources/cdc-2023-hepatitis-b-screening-and-testing-recommendations.md?locale=en
Original URL: https://www.cdc.gov/mmwr/volumes/72/rr/rr7201a1.htm

## Metadata

- Organization: Centers for Disease Control and Prevention
- Country or region: United States
- Language: en
- Source type: guideline
- Published: not listed
- Source updated: not listed
- Last checked by OpenHBV: 2026-06-26
- Credibility note: 国家公共卫生机构

## Summary

CDC 2023 年乙肝筛查和检测建议，包含成人一次性三项筛查，以及接受或需要细胞毒性、免疫抑制或免疫调节治疗人群的检测建议。

## Related OpenHBV Articles

- Hepatitis B with HIV or hepatitis C: tests, medicines, and follow-up points
  URL: https://openhbv.bangbo.dev/articles/hepatitis-b-with-hiv-or-hepatitis-c-tests-medicines-and-follow-up-points?locale=en
  Markdown: https://openhbv.bangbo.dev/articles/hepatitis-b-with-hiv-or-hepatitis-c-tests-medicines-and-follow-up-points.md?locale=en
  Translation key: article-4ff4f9de9e07
  Language: en
  Topic: Test Results
  Published: 2026-06-26
  Review status: source_backed
  Last reviewed: 2026-06-26
  Summary: What to prepare when hepatitis B overlaps with HIV, hepatitis C, or related treatment decisions, and why HBV-active medicines should not be stopped on your own.
- Before chemotherapy, immunosuppression, or biologics: do not miss hepatitis B reactivation risk
  URL: https://openhbv.bangbo.dev/articles/before-chemotherapy-immunosuppression-or-biologics-do-not-miss-hepatitis-b-reactivation-risk?locale=en
  Markdown: https://openhbv.bangbo.dev/articles/before-chemotherapy-immunosuppression-or-biologics-do-not-miss-hepatitis-b-reactivation-risk.md?locale=en
  Translation key: article-8c0fbf61e461
  Language: en
  Topic: Treatment and Follow-up
  Published: 2026-06-26
  Review status: source_backed
  Last reviewed: 2026-06-26
  Summary: What HBV reactivation means, which treatments should trigger screening, and what to ask before cancer or immune-suppressing therapy starts.

## Use Notes

This page is a source record, not medical advice. Use the original source URL above to verify claims, publication details, updates, and scope. OpenHBV records the last checked date so readers and LLM retrieval systems can judge freshness.
